SHANGHAI, China, Feb. 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (“WuXi PharmaTech” or “the Company”), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release unaudited financial results for the fourth quarter and full year ended December 31, 2007 after the US market close on Wednesday, March 12, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The earnings release will be available on the investor relations page of its website at http://www.wuxipharmatech.com .
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 9:00 am (Eastern) / 6:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong) on Thursday, March 13, 2008 to discuss its 2007 fourth quarter and full year financial results and recent business activity. The conference call may be accessed by calling:
A telephone replay will be available shortly after the call until April 12, 2008 at (US) +1-888-203-1112/ (HK) +800-901-108 / (China, Southern Region) +10-800-140-1178 / (China, Northern Region) +1-719-457-0820 / (UK) +0808-101- 1153. Passcode: 2224172.
A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech’s website at http://www.wuxipharmatech.com .
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech, headquartered in Shanghai, China, is the leading global pharmaceutical, biotechnology and medical device R&D outsourcing company. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory, research manufacturing, biologics testing and manufacturing services throughout the drug and medical device research and development process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device research and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. For more information, please visit: http://www.wuxipharmatech.com .
ir@pharmatechs.comPharmatechs@taylor-rafferty.comPharmatechs@taylor-rafferty.comPharmatechs@taylor-rafferty.com
CONTACT: Hai Mi, Ph.D., Vice President, Corporate Communications of WuXi
PharmaTech Co., Ltd. at +86-21-5046-3726 or mi_hai@pharmatechs.com;
Investor Relations (HK): Ruby Yim, Managing Director of Taylor Rafferty at
+852-3196-3712 or Pharmatechs@taylor-rafferty.com; Investor Relations (US):
Mahmoud Siddig, Director of Taylor Rafferty at +1-212-889-4350 or
Pharmatechs@taylor-rafferty.com; Media: John Dooley of Taylor Rafferty at
+1- 212-889-4350 or Pharmatechs@taylor-rafferty.com
Web site: http://www.wuxipharmatech.com/
